The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2026
Filed:
Sep. 30, 2020
Applicants:
Asahi Kasei Pharma Corporation, Tokyo, JP;
Vernalis (R&d) Limited, Cambridge, GB;
Inventors:
Koichiro Arai, Tokyo, JP;
Kenichiro Takaba, Tokyo, JP;
Masakazu Atobe, Tokyo, JP;
Misato Takashima, Tokyo, JP;
Naomi Aono, Tokyo, JP;
Andrew John Potter, Cambridge, GB;
Daniel Paul Maddox, Cambridge, GB;
Assignees:
ASAHI KASEI PHARMA CORPORATION, Tokyo, JP;
VERNALIS (R&D) LIMITED, Cambridge, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61P 19/02 (2006.01); A61P 35/02 (2006.01); C07D 417/08 (2006.01); C07D 417/14 (2006.01); C07D 491/107 (2006.01); C07D 498/18 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61P 19/02 (2018.01); A61P 35/02 (2018.01); C07D 417/08 (2013.01); C07D 417/14 (2013.01); C07D 491/107 (2013.01); C07D 498/18 (2013.01);
Abstract
A compound represented by the general formula (1) or a salt thereof, which has a superior IRAK-4 inhibitory activity, and is useful as active ingredients of medicaments for prophylactic treatment and/or therapeutic treatment of diseases relating to IRAK-4 inhibition.